Development
Evaxion Biotech A/S
EVAX
$3.13
$0.5521.32%
NASDAQ
| 09/30/2023 | 06/30/2023 | 12/31/2022 | 09/30/2022 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -71.81% | -59.01% | -- | |
| Total Receivables | -- | -29.24% | -31.25% | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | -- | 75.92% | 290.91% | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | -- | -60.16% | -51.06% | -- | |
|
|
|||||
| Total Current Assets | -- | -60.16% | -51.06% | -- | |
| Net Property, Plant & Equipment | -- | -2.98% | -9.64% | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -- | 20.72% | 91.10% | -- | |
| Total Assets | -- | -50.73% | -45.16% | -- | |
|
|
|||||
| Total Accounts Payable | -- | -30.91% | -26.79% | -- | |
| Total Accrued Expenses | -- | -- | -64.31% | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | 14.36% | -0.23% | -- | |
| Total Finance Division Other Current Liabilities | -- | 21.63% | 1,823.91% | -- | |
| Total Other Current Liabilities | -- | 21.63% | 1,823.91% | -- | |
| Total Current Liabilities | -- | -8.12% | -12.98% | -- | |
|
|
|||||
| Total Current Liabilities | -- | -8.12% | -12.98% | -- | |
| Long-Term Debt | -- | 10.06% | 653.26% | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -1.07% | -11.51% | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | 4.26% | -5.88% | -- | |
| Total Liabilities | -- | 2.63% | 77.61% | -- | |
|
|
|||||
| Common Stock & APIC | -- | 7.63% | 0.51% | -- | |
| Retained Earnings | -- | -39.67% | -44.07% | -- | |
| Treasury Stock & Other | -- | -2.75% | -177.43% | -- | |
| Total Common Equity | -- | -87.42% | -74.40% | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -- | -87.42% | -74.40% | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -- | -87.42% | -74.40% | -- | |
|
|
|||||